-
1دورية أكاديمية
المؤلفون: Hughes, Gareth, Dark, Paul
المصدر: RECOVERY Collaborative Group , Hughes , G & Dark , P 2024 , ' Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY) : a randomised, controlled, open-label, platform trial ' , The Lancet. Child & adolescent health , vol. 8 , no. 3 , pp. 190-200 . https://doi.org/10.1016/S2352-4642Test(23)00316-4
مصطلحات موضوعية: Humans, Male, Child, Female, COVID-19/complications, SARS-CoV-2, Interleukin 1 Receptor Antagonist Protein/therapeutic use, Immunoglobulins, Intravenous/therapeutic use, Bayes Theorem, Treatment Outcome, Methylprednisolone/therapeutic use, Inflammation, Immunomodulation, Systemic Inflammatory Response Syndrome
الإتاحة: https://doi.org/10.1016/S2352-4642Test(23)00316-4
https://research.manchester.ac.uk/en/publications/4c324435-1ff8-4b23-b729-558db148d055Test -
2
المؤلفون: Caroline Vinit, Sophie Georgin-Lavialle, Aikaterini Theodoropoulou, Catherine Barbier, Alexandre Belot, Manel Mejbri, Pascal Pillet, Jana Pachlopnik, Sylvaine Poignant, Charlotte Rebelle, Andreas Woerner, Isabelle Koné-Paut, Véronique Hentgen
المساهمون: Centre Hospitalier de Versailles André Mignot (CHV), Service de Médecine Interne [CHU Tenon], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Tenon [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Lausanne University Hospital, Centre Hospitalier Universitaire [Grenoble] (CHU), Service de néphrologie, rhumatologie et dermatologie pédiatriques [Hôpital Femme Mère Enfant, HCL], Hospices Civils de Lyon (HCL)-Hôpital Mère Enfant, CHU Bordeaux [Bordeaux], Département de pédiatrie [CHU Nantes], Centre hospitalier universitaire de Nantes (CHU Nantes), CHU de Bordeaux Pellegrin [Bordeaux], University Children’s Hospital Basel = Hôpital pédiatrique universitaire des deux Bâle [Bâle, Suisse] (UKBB), Service de Rhumatologie [CHU Bicêtre], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Bicêtre
المصدر: Frontiers in Immunology, Vol 12 (2021)
Frontiers in immunology, vol. 12, pp. 744780
Frontiers in Immunology
Frontiers in Immunology, Frontiers, 2021, 12, ⟨10.3389/fimmu.2021.744780⟩مصطلحات موضوعية: Male, Familial Mediterranean fever, interleukin-1 blockers, Adolescent, Adult, Aged, Antibodies, Monoclonal, Humanized/therapeutic use, Antirheumatic Agents/therapeutic use, Child, Child, Preschool, Female, Hereditary Autoinflammatory Diseases/complications, Hereditary Autoinflammatory Diseases/drug therapy, Humans, Infant, Interleukin 1 Receptor Antagonist Protein/therapeutic use, Interleukin-1/antagonists & inhibitors, Middle Aged, Retrospective Studies, Young Adult, anakinra, autoinflammatory diseases, canakinumab, hereditary recurrent fevers, indications, treatment, 0302 clinical medicine, Quality of life, Immunology and Allergy, Original Research, 0303 health sciences, Mevalonate kinase deficiency, Interleukin, 3. Good health, Antirheumatic Agents, [SDV.IMM]Life Sciences [q-bio]/Immunology, medicine.drug, medicine.medical_specialty, Immunology, MEDLINE, Antibodies, Monoclonal, Humanized, 03 medical and health sciences, Internal medicine, medicine, 030304 developmental biology, 030203 arthritis & rheumatology, Anakinra, business.industry, Hereditary Autoinflammatory Diseases, RC581-607, medicine.disease, Canakinumab, Interleukin 1 Receptor Antagonist Protein, Immunologic diseases. Allergy, Complication, business, Interleukin-1
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e625e3774c42c4cbcb268ba3e8a594dTest
https://www.frontiersin.org/articles/10.3389/fimmu.2021.744780/fullTest -
3تقرير
المؤلفون: Gran, Jan Tore, Midtvedt, Öyvind, Haug, Sidsel
المصدر: Tidsskrift for Den Norske Laegeforening. 131(2):135
-
4دورية أكاديمية
المؤلفون: Saag, K.G., Khanna, P.P., Keenan, R.T., Ohlman, S., Osterling Koskinen, L., Sparve, E., Åkerblad, A.C., Wikén, M., So, A., Pillinger, M.H., Terkeltaub, R.
المصدر: Arthritis & rheumatology, vol. 73, no. 8, pp. 1533-1542
مصطلحات موضوعية: Adult, Aged, 80 and over, Arthralgia/drug therapy, Arthralgia/etiology, Double-Blind Method, Female, Gout/complications, Gout/drug therapy, Humans, Interleukin 1 Receptor Antagonist Protein/therapeutic use, Male, Middle Aged, Pain Measurement, Patient Reported Outcome Measures, Symptom Flare Up, Treatment Outcome, Triamcinolone/therapeutic use
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/33605029; info:eu-repo/semantics/altIdentifier/eissn/2326-5205; https://serval.unil.ch/notice/serval:BIB_152DC8683A89Test; urn:issn:2326-5191
الإتاحة: https://doi.org/10.1002/art.41699Test
https://serval.unil.ch/notice/serval:BIB_152DC8683A89Test -
5
المؤلفون: Kearsley-Fleet, Lianne, Beresford, Michael W, Davies, Rebecca, De Cock, Diederik, Baildam, Eileen, Foster, Helen E, Southwood, Taunton R, Thomson, Wendy, Hyrich, Kimme L, Dis, Biologics Children Rheumatic
المساهمون: Public Health Sciences
المصدر: Rheumatology (Oxford, England)
RHEUMATOLOGY
Kearsley-Fleet, L, Beresford, M W, Davies, R, De Cock, D, Baildam, E, Foster, H E, Southwood, T R, Thomson, W, Hyrich, K L & Biologics for Children with Rheumatic Diseases Study (BCRD) 2019, ' Short-Term Outcomes in Patients with Systemic Juvenile Idiopathic Arthritis Treated with either Tocilizumab or Anakinra ', Rheumatology (Oxford), vol. 58, no. 1, pp. 94-102 . https://doi.org/10.1093/rheumatology/key262Testمصطلحات موضوعية: Male, Time Factors, Epidemiology, Arthritis, Antirheumatic Agents/therapeutic use, Outcome measures, Severity of Illness Index, Biologic Therapies, chemistry.chemical_compound, 0302 clinical medicine, Pharmacology (medical), Arthritis, Juvenile/drug therapy, 030212 general & internal medicine, Child, skin and connective tissue diseases, Statistics, Induction Chemotherapy, Clinical Science, Treatment Outcome, Antibodies, Monoclonal, Humanized/therapeutic use, statistics, Antirheumatic Agents, Child, Preschool, Cohort, epidemiology, Female, Biological Products/therapeutic use, medicine.drug, musculoskeletal diseases, medicine.medical_specialty, Antibodies, Monoclonal, Humanized, Interleukin 1 Receptor Antagonist Protein/therapeutic use, outcome measures, 03 medical and health sciences, Tocilizumab, Rheumatology, biologic therapies, Internal medicine, Severity of illness, medicine, Humans, Juvenile Idiopathic Arthritis, JIA, 030203 arthritis & rheumatology, Biological Products, Anakinra, business.industry, Induction chemotherapy, medicine.disease, Arthritis, Juvenile, Interleukin 1 Receptor Antagonist Protein, Logistic Models, chemistry, Macrophage activation syndrome, business
وصف الملف: application/vnd.openxmlformats-officedocument.wordprocessingml.document
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff89dce7fd1afb5b2ae4989dbed4d264Test
https://doi.org/10.1093/rheumatology/key262Test -
6دورية أكاديمية
المؤلفون: Ter Haar, N.M., Eijkelboom, C., Cantarini, L., Papa, R., Brogan, P.A., Kone-Paut, I., Modesto, C., Hofer, M., Iagaru, N., Fingerhutová, S., Insalaco, A., Licciardi, F., Uziel, Y., Jelusic, M., Nikishina, I., Nielsen, S., Papadopoulou-Alataki, E., Olivieri, A.N., Cimaz, R., Susic, G., Stanevica, V., van Gijn, M., Vitale, A., Ruperto, N., Frenkel, J., Gattorno, M.
المساهمون: Eurofever registry and the Pediatric Rheumatology International Trial Organization (PRINTO)
المصدر: Annals of the rheumatic diseases, vol. 78, no. 10, pp. 1405-1411
مصطلحات موضوعية: Adolescent, Adrenal Cortex Hormones/therapeutic use, Adult, Age of Onset, Antirheumatic Agents/therapeutic use, Child, Preschool, Chronic Disease, Colchicine/therapeutic use, Europe, Female, Genetic Variation/genetics, Hereditary Autoinflammatory Diseases/drug therapy, Hereditary Autoinflammatory Diseases/genetics, Hereditary Autoinflammatory Diseases/pathology, Humans, Interleukin 1 Receptor Antagonist Protein/therapeutic use, Male, Pedigree, Registries, Retrospective Studies, Young Adult, autoinflammatory diseases, eurofever, inflammation, recurrent fever
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/31278138; info:eu-repo/semantics/altIdentifier/eissn/1468-2060; https://serval.unil.ch/notice/serval:BIB_5E7B2C4FA362Test; urn:issn:0003-4967
الإتاحة: https://doi.org/10.1136/annrheumdis-2018-214472Test
https://serval.unil.ch/notice/serval:BIB_5E7B2C4FA362Test -
7دورية أكاديمية
المؤلفون: Ly, Kim-Heang, Stirnemann, Jérôme, Liozon, Eric, Michel, Marc, Fain, Olivier, Fauchais, Anne-Laure
المصدر: ISSN: 1297-319X ; Joint bone spine, vol. 81, no. 1 (2014) p. 76-78.
مصطلحات موضوعية: Aged, 80 and over, Antirheumatic Agents/therapeutic use, Female, Giant Cell Arteritis/drug therapy/radionuclide imaging, Glucocorticoids/therapeutic use, Humans, Interleukin 1 Receptor Antagonist Protein/therapeutic use, Interleukin-1/antagonists & inhibitors, Male, Positron-Emission Tomography
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/23890680; https://archive-ouverte.unige.ch/unige:78459Test; unige:78459
-
8
المؤلفون: K.H. Ly, Marc Michel, Olivier Fain, Jérôme Stirnemann, Eric Liozon, Anne-Laure Fauchais
المصدر: Joint, Bone, Spine, Vol. 81, No 1 (2014) pp. 76-78
مصطلحات موضوعية: Glucocorticoids/therapeutic use, Male, Pathology, medicine.medical_specialty, Intimal hyperplasia, Giant Cell Arteritis, Inflammation, Antirheumatic Agents/therapeutic use, Interleukin-1/antagonists & inhibitors, Interleukin 1 Receptor Antagonist Protein/therapeutic use, Pathogenesis, Rheumatology, medicine, Giant Cell Arteritis/drug therapy/radionuclide imaging, Humans, Glucocorticoids, Aged, Aged, 80 and over, Anakinra, business.industry, medicine.disease, Arterial occlusion, Giant cell arteritis, Interleukin 1 Receptor Antagonist Protein, Antirheumatic Agents, Positron-Emission Tomography, Tumor necrosis factor alpha, Female, medicine.symptom, Vasculitis, business, medicine.drug, Interleukin-1
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3894ab9620b3e20fe15bf61de2609808Test
https://archive-ouverte.unige.ch/unige:78459Test -
9دورية أكاديمية
المؤلفون: Gabay, Cem, Lamacchia, Céline, Palmer-Lourenco, Gaby
المصدر: ISSN: 1759-4790 ; Nature reviews. Rheumatology, vol. 6, no. 4 (2010) p. 232-241.
مصطلحات موضوعية: info:eu-repo/classification/ddc/616, Animals, Cohort Studies, Disease Models, Animal, Drug Delivery Systems, Female, Humans, Inflammation/blood/physiopathology, Inflammation Mediators/blood, Interleukin 1 Receptor Antagonist Protein/therapeutic use, Interleukin-1/*antagonists & inhibitors/*metabolism, Interleukin-1beta/drug effects/metabolism, Male, Mice, Prognosis, Receptors, Interleukin/antagonists & inhibitors/drug effects, Rheumatic Diseases/*blood/diagnosis/*drug therapy, Risk Assessment, Signal Transduction, Treatment Outcome
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/20177398; https://archive-ouverte.unige.ch/unige:20951Test; unige:20951
-
10
المؤلفون: Gaby Palmer, Cem Gabay, Céline Lamacchia
المصدر: Nature Reviews Rheumatology, Vol. 6, No 4 (2010) pp. 232-241
مصطلحات موضوعية: Male, Receptors, Interleukin/antagonists & inhibitors/drug effects, Rheumatic Diseases/*blood/diagnosis/*drug therapy, medicine.drug_class, Interleukin-1beta, Inflammation/blood/physiopathology, Arthritis, Still Disease, Inflammation, Type 2 diabetes, Risk Assessment, Interleukin 1 Receptor Antagonist Protein/therapeutic use, Cohort Studies, Mice, Drug Delivery Systems, Rheumatology, Rheumatic Diseases, medicine, Animals, Humans, Receptor, ddc:616, Interleukin-1/*antagonists & inhibitors/*metabolism, business.industry, Interleukin, Receptors, Interleukin, medicine.disease, Receptor antagonist, Prognosis, Interleukin-1beta/drug effects/metabolism, Interleukin 1 Receptor Antagonist Protein, Disease Models, Animal, Treatment Outcome, Rheumatoid arthritis, Inflammation Mediators/blood, Immunology, Female, medicine.symptom, Inflammation Mediators, business, Interleukin-1, Signal Transduction
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b01aff0fab36ea7e6cc2eef23d0bfdeTest
https://archive-ouverte.unige.ch/unige:20951Test